The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 142.00
Ask: 147.50
Change: -1.00 (-0.70%)
Spread: 5.50 (3.873%)
Open: 140.50
High: 142.00
Low: 140.50
Prev. Close: 143.00
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Jan 2024 16:00

RNS Number : 9966Y
Redcentric PLC
08 January 2024

Redcentric plc

Director/PDMR Shareholdings

Redcentric plc (AIM:RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, received notification from Kestrel Partners LLP ("Kestrel") that on 04 January 2024 and 05 January 2024 it purchased, on behalf of its discretionary client accounts, an aggregate of 10,705 ordinary shares of 0.1 pence each ("Ordinary Shares") in the Company at an average price of £1.2746 per Ordinary Share.

Mr Oliver Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 16,402,618 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 15,585,201 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 31,987,819 Ordinary Shares in the Company, which represents approximately 20.46 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,402,618

10.49%

Indirect

JIM Nominees Limited

464,310

0.30%

Indirect

Bank of New York Nominees Ltd

12,238,465

7.83%

Indirect

Northern Trust Company AVFC

2,882,426

1.84%

For further information contact:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

+44 (0) 800 983 2522

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0) 20 7220 0500

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP

2

Reason for the notification

a)

Position/status

PCA - Oliver Scott (non-executive director Redcentric plc)

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

0.1 pence Ordinary Shares

ISIN: GB00B7TW1V39

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Transfer

Purchase

04 January 2024

Price(s)

Volume(s)

£1.2781

4,890

05 January 2024

Price(s)

Volume(s)

£1.2717

5,815

d)

Aggregated information

- Aggregated volume

- Price

Purchase Total of 10,705 Ordinary Shares at a price of £1.2746

e)

Date of the transaction

04 January 2024, 05 January 2024

f)

Place of the transaction

London AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBPMATMTAMBFI
Date   Source Headline
15th Nov 20227:00 amRNSTrading Update
2nd Nov 20227:00 amRNSExercise of Options
26th Oct 20227:00 amRNSExercise of Options
19th Oct 20227:00 amRNSExercise of Options
13th Oct 20222:06 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSGrant of Options and Director/PDMR Shareholding
5th Oct 202210:57 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSExercise of Options
16th Sep 202212:36 pmRNSHolding(s) in Company
15th Sep 202212:54 pmRNSHolding(s) in Company
15th Sep 202212:25 pmRNSExercise of Options and PDMR Shareholding
14th Sep 20227:00 amRNSExercise of Options
13th Sep 202211:52 amRNSHolding(s) in Company
7th Sep 20224:28 pmRNSResult of AGM
6th Sep 20227:00 amRNSExercise of Options
5th Sep 20221:53 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSSave As You Earn Share Option Scheme
30th Aug 20227:00 amRNSExercise of Options
23rd Aug 20229:23 amRNSExercise of Options
17th Aug 20227:00 amRNSExercise of Options
8th Aug 20227:00 amRNSPublication of Annual Report and Notice of AGM
1st Aug 202212:10 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSExercise of Options
22nd Jul 202212:08 pmRNSHolding(s) in Company
21st Jul 20227:01 amRNSAlan Aubrey - AIM Rule 17 Disclosures
21st Jul 20227:00 amRNSPreliminary results announcement FY22
19th Jul 202212:19 pmRNSHolding(s) in Company
12th Jul 20227:00 amRNSAcquisition of Sungard data centres and 4D
7th Jul 20226:25 pmRNSCompletion of Acquisitions
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
9th Jun 20227:00 amRNSDirector/PDMR Shareholding
7th Jun 20228:07 amRNSAcquisition of business and assets of Sungard
12th May 20227:00 amRNSDirectorate Change
28th Apr 20227:00 amRNSTrading Update
27th Apr 20227:00 amRNSNew £100m Bank Facilities
21st Apr 20227:00 amRNSExercise of Options
17th Mar 20227:00 amRNSExercise of Options
15th Mar 20227:00 amRNSAcquisition of 7 Elements Limited
24th Feb 202211:29 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSResponse to outcome of FCA criminal prosecutions
2nd Feb 20221:43 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.